nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosaprepitant—TACR1—forebrain—Alzheimer's disease	0.0107	0.294	CbGeAlD
Fosaprepitant—TACR1—telencephalon—Alzheimer's disease	0.00984	0.271	CbGeAlD
Fosaprepitant—TACR1—nervous system—Alzheimer's disease	0.00581	0.16	CbGeAlD
Fosaprepitant—TACR1—central nervous system—Alzheimer's disease	0.00559	0.154	CbGeAlD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	0.00529	0.0252	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—GFAP—Alzheimer's disease	0.00484	0.023	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—PYY—Alzheimer's disease	0.00477	0.0227	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	0.0045	0.0214	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	0.0045	0.0214	CbGpPWpGaD
Fosaprepitant—TACR1—brain—Alzheimer's disease	0.00444	0.122	CbGeAlD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	0.00436	0.0207	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	0.00383	0.0182	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	0.0036	0.0171	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	0.00353	0.0168	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—PPP3CA—Alzheimer's disease	0.00346	0.0164	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—GAL—Alzheimer's disease	0.00331	0.0157	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.00323	0.0154	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—PYY—Alzheimer's disease	0.0032	0.0152	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide GPCRs—CCR5—Alzheimer's disease	0.0031	0.0148	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.00293	0.0139	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.0029	0.0138	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—NGFR—Alzheimer's disease	0.00285	0.0135	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	0.00273	0.013	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—HTR6—Alzheimer's disease	0.00267	0.0127	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.00265	0.0126	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.00265	0.0126	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—NPY—Alzheimer's disease	0.0026	0.0123	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—BDNF—Alzheimer's disease	0.00248	0.0118	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—PYY—Alzheimer's disease	0.00244	0.0116	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—NPS—Alzheimer's disease	0.00241	0.0114	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—IL1A—Alzheimer's disease	0.00238	0.0113	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—NPS—Alzheimer's disease	0.00237	0.0113	CbGpPWpGaD
Fosaprepitant—Angiopathy—Galantamine—Alzheimer's disease	0.00232	0.00309	CcSEcCtD
Fosaprepitant—Hypokalaemia—Rivastigmine—Alzheimer's disease	0.00232	0.00308	CcSEcCtD
Fosaprepitant—Dysuria—Donepezil—Alzheimer's disease	0.00232	0.00308	CcSEcCtD
Fosaprepitant—Immune system disorder—Galantamine—Alzheimer's disease	0.00231	0.00307	CcSEcCtD
Fosaprepitant—Muscular weakness—Memantine—Alzheimer's disease	0.0023	0.00305	CcSEcCtD
Fosaprepitant—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.0023	0.00305	CcSEcCtD
Fosaprepitant—Pollakiuria—Donepezil—Alzheimer's disease	0.00229	0.00304	CcSEcCtD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—SST—Alzheimer's disease	0.00227	0.0108	CbGpPWpGaD
Fosaprepitant—Muscular weakness—Rivastigmine—Alzheimer's disease	0.00225	0.00298	CcSEcCtD
Fosaprepitant—Mental disorder—Galantamine—Alzheimer's disease	0.00224	0.00298	CcSEcCtD
Fosaprepitant—Weight decreased—Donepezil—Alzheimer's disease	0.00224	0.00298	CcSEcCtD
Fosaprepitant—TACR1—G alpha (q) signalling events—APP—Alzheimer's disease	0.00224	0.0106	CbGpPWpGaD
Fosaprepitant—Malnutrition—Galantamine—Alzheimer's disease	0.00223	0.00296	CcSEcCtD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—GAL—Alzheimer's disease	0.00222	0.0105	CbGpPWpGaD
Fosaprepitant—Infestation—Donepezil—Alzheimer's disease	0.00221	0.00294	CcSEcCtD
Fosaprepitant—Infestation NOS—Donepezil—Alzheimer's disease	0.00221	0.00294	CcSEcCtD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—APP—Alzheimer's disease	0.00221	0.0105	CbGpPWpGaD
Fosaprepitant—Flatulence—Galantamine—Alzheimer's disease	0.0022	0.00292	CcSEcCtD
Fosaprepitant—Dysgeusia—Galantamine—Alzheimer's disease	0.00218	0.0029	CcSEcCtD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—Alzheimer's disease	0.00215	0.0102	CbGpPWpGaD
Fosaprepitant—Urinary tract infection—Donepezil—Alzheimer's disease	0.00215	0.00285	CcSEcCtD
Fosaprepitant—Conjunctivitis—Donepezil—Alzheimer's disease	0.00215	0.00285	CcSEcCtD
Fosaprepitant—Muscle spasms—Galantamine—Alzheimer's disease	0.00214	0.00285	CcSEcCtD
Fosaprepitant—TACR1—G alpha (q) signalling events—PLCB1—Alzheimer's disease	0.00211	0.01	CbGpPWpGaD
Fosaprepitant—Haematuria—Donepezil—Alzheimer's disease	0.00211	0.0028	CcSEcCtD
Fosaprepitant—Dysuria—Memantine—Alzheimer's disease	0.00211	0.0028	CcSEcCtD
Fosaprepitant—Pollakiuria—Memantine—Alzheimer's disease	0.00208	0.00276	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00207	0.00275	CcSEcCtD
Fosaprepitant—Anaemia—Galantamine—Alzheimer's disease	0.00206	0.00274	CcSEcCtD
Fosaprepitant—Dysuria—Rivastigmine—Alzheimer's disease	0.00206	0.00273	CcSEcCtD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	0.00204	0.00968	CbGpPWpGaD
Fosaprepitant—Weight decreased—Memantine—Alzheimer's disease	0.00204	0.0027	CcSEcCtD
Fosaprepitant—Pollakiuria—Rivastigmine—Alzheimer's disease	0.00203	0.0027	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—HTR6—Alzheimer's disease	0.00203	0.00966	CbGpPWpGaD
Fosaprepitant—Bradycardia—Donepezil—Alzheimer's disease	0.00202	0.00268	CcSEcCtD
Fosaprepitant—Malaise—Galantamine—Alzheimer's disease	0.00201	0.00267	CcSEcCtD
Fosaprepitant—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.00201	0.00267	CcSEcCtD
Fosaprepitant—Infestation NOS—Memantine—Alzheimer's disease	0.00201	0.00267	CcSEcCtD
Fosaprepitant—Infestation—Memantine—Alzheimer's disease	0.00201	0.00267	CcSEcCtD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—APP—Alzheimer's disease	0.002	0.0095	CbGpPWpGaD
Fosaprepitant—Syncope—Galantamine—Alzheimer's disease	0.002	0.00265	CcSEcCtD
Fosaprepitant—Weight decreased—Rivastigmine—Alzheimer's disease	0.00199	0.00265	CcSEcCtD
Fosaprepitant—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.00199	0.00264	CcSEcCtD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	0.00198	0.00941	CbGpPWpGaD
Fosaprepitant—Hypoaesthesia—Donepezil—Alzheimer's disease	0.00198	0.00262	CcSEcCtD
Fosaprepitant—Palpitations—Galantamine—Alzheimer's disease	0.00197	0.00262	CcSEcCtD
Fosaprepitant—Infestation—Rivastigmine—Alzheimer's disease	0.00196	0.00261	CcSEcCtD
Fosaprepitant—Infestation NOS—Rivastigmine—Alzheimer's disease	0.00196	0.00261	CcSEcCtD
Fosaprepitant—Urinary tract disorder—Donepezil—Alzheimer's disease	0.00196	0.0026	CcSEcCtD
Fosaprepitant—Loss of consciousness—Galantamine—Alzheimer's disease	0.00196	0.0026	CcSEcCtD
Fosaprepitant—Urinary tract infection—Memantine—Alzheimer's disease	0.00195	0.00259	CcSEcCtD
Fosaprepitant—Conjunctivitis—Memantine—Alzheimer's disease	0.00195	0.00259	CcSEcCtD
Fosaprepitant—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.00195	0.00259	CcSEcCtD
Fosaprepitant—Urethral disorder—Donepezil—Alzheimer's disease	0.00195	0.00258	CcSEcCtD
Fosaprepitant—Cough—Galantamine—Alzheimer's disease	0.00195	0.00258	CcSEcCtD
Fosaprepitant—TACR1—Spinal Cord Injury—LEP—Alzheimer's disease	0.00194	0.00924	CbGpPWpGaD
Fosaprepitant—Hypertension—Galantamine—Alzheimer's disease	0.00193	0.00256	CcSEcCtD
Fosaprepitant—Haematuria—Memantine—Alzheimer's disease	0.00191	0.00254	CcSEcCtD
Fosaprepitant—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.00191	0.00253	CcSEcCtD
Fosaprepitant—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.00191	0.00253	CcSEcCtD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	0.0019	0.00903	CbGpPWpGaD
Fosaprepitant—Chest pain—Galantamine—Alzheimer's disease	0.0019	0.00252	CcSEcCtD
Fosaprepitant—Anxiety—Galantamine—Alzheimer's disease	0.00189	0.00251	CcSEcCtD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—PLCB1—Alzheimer's disease	0.00189	0.00897	CbGpPWpGaD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00189	0.0025	CcSEcCtD
Fosaprepitant—Discomfort—Galantamine—Alzheimer's disease	0.00188	0.00249	CcSEcCtD
Fosaprepitant—Haematuria—Rivastigmine—Alzheimer's disease	0.00187	0.00249	CcSEcCtD
Fosaprepitant—Dry mouth—Galantamine—Alzheimer's disease	0.00186	0.00246	CcSEcCtD
Fosaprepitant—Tinnitus—Donepezil—Alzheimer's disease	0.00185	0.00246	CcSEcCtD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	0.00184	0.00874	CbGpPWpGaD
Fosaprepitant—Bradycardia—Memantine—Alzheimer's disease	0.00183	0.00244	CcSEcCtD
Fosaprepitant—TACR1—Spinal Cord Injury—NOS2—Alzheimer's disease	0.00181	0.00861	CbGpPWpGaD
Fosaprepitant—Bradycardia—Rivastigmine—Alzheimer's disease	0.0018	0.00238	CcSEcCtD
Fosaprepitant—Hypoaesthesia—Memantine—Alzheimer's disease	0.00179	0.00238	CcSEcCtD
Fosaprepitant—Shock—Galantamine—Alzheimer's disease	0.00179	0.00238	CcSEcCtD
Fosaprepitant—Nervous system disorder—Galantamine—Alzheimer's disease	0.00178	0.00237	CcSEcCtD
Fosaprepitant—Urinary tract disorder—Memantine—Alzheimer's disease	0.00178	0.00236	CcSEcCtD
Fosaprepitant—Connective tissue disorder—Memantine—Alzheimer's disease	0.00177	0.00235	CcSEcCtD
Fosaprepitant—Skin disorder—Galantamine—Alzheimer's disease	0.00177	0.00235	CcSEcCtD
Fosaprepitant—Urethral disorder—Memantine—Alzheimer's disease	0.00177	0.00235	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00176	0.00234	CcSEcCtD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	0.00176	0.00835	CbGpPWpGaD
Fosaprepitant—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.00175	0.00233	CcSEcCtD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	0.00174	0.00828	CbGpPWpGaD
Fosaprepitant—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.00174	0.00231	CcSEcCtD
Fosaprepitant—Mental disorder—Donepezil—Alzheimer's disease	0.00174	0.00231	CcSEcCtD
Fosaprepitant—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00173	0.0023	CcSEcCtD
Fosaprepitant—Urethral disorder—Rivastigmine—Alzheimer's disease	0.00173	0.00229	CcSEcCtD
Fosaprepitant—Malnutrition—Donepezil—Alzheimer's disease	0.00173	0.00229	CcSEcCtD
Fosaprepitant—Erythema—Donepezil—Alzheimer's disease	0.00173	0.00229	CcSEcCtD
Fosaprepitant—Erythema multiforme—Memantine—Alzheimer's disease	0.0017	0.00226	CcSEcCtD
Fosaprepitant—Flatulence—Donepezil—Alzheimer's disease	0.0017	0.00226	CcSEcCtD
Fosaprepitant—Hypotension—Galantamine—Alzheimer's disease	0.0017	0.00226	CcSEcCtD
Fosaprepitant—Dysgeusia—Donepezil—Alzheimer's disease	0.00169	0.00225	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—GAL—Alzheimer's disease	0.00169	0.00802	CbGpPWpGaD
Fosaprepitant—Eye disorder—Memantine—Alzheimer's disease	0.00168	0.00224	CcSEcCtD
Fosaprepitant—Tinnitus—Memantine—Alzheimer's disease	0.00168	0.00223	CcSEcCtD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	0.00167	0.00795	CbGpPWpGaD
Fosaprepitant—Flushing—Memantine—Alzheimer's disease	0.00167	0.00222	CcSEcCtD
Fosaprepitant—Cardiac disorder—Memantine—Alzheimer's disease	0.00167	0.00222	CcSEcCtD
Fosaprepitant—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.00167	0.00221	CcSEcCtD
Fosaprepitant—Muscle spasms—Donepezil—Alzheimer's disease	0.00166	0.00221	CcSEcCtD
Fosaprepitant—Eye disorder—Rivastigmine—Alzheimer's disease	0.00165	0.00219	CcSEcCtD
Fosaprepitant—Insomnia—Galantamine—Alzheimer's disease	0.00165	0.00219	CcSEcCtD
Fosaprepitant—Tinnitus—Rivastigmine—Alzheimer's disease	0.00164	0.00218	CcSEcCtD
Fosaprepitant—Flushing—Rivastigmine—Alzheimer's disease	0.00164	0.00217	CcSEcCtD
Fosaprepitant—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00164	0.00217	CcSEcCtD
Fosaprepitant—Angiopathy—Memantine—Alzheimer's disease	0.00164	0.00217	CcSEcCtD
Fosaprepitant—TACR1—Spinal Cord Injury—CCL2—Alzheimer's disease	0.00163	0.00777	CbGpPWpGaD
Fosaprepitant—Immune system disorder—Memantine—Alzheimer's disease	0.00163	0.00216	CcSEcCtD
Fosaprepitant—Mediastinal disorder—Memantine—Alzheimer's disease	0.00162	0.00216	CcSEcCtD
Fosaprepitant—Somnolence—Galantamine—Alzheimer's disease	0.00162	0.00215	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Donepezil—Alzheimer's disease	0.0016	0.00213	CcSEcCtD
Fosaprepitant—Dyspepsia—Galantamine—Alzheimer's disease	0.0016	0.00213	CcSEcCtD
Fosaprepitant—Angiopathy—Rivastigmine—Alzheimer's disease	0.0016	0.00212	CcSEcCtD
Fosaprepitant—Anaemia—Donepezil—Alzheimer's disease	0.0016	0.00212	CcSEcCtD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	0.00159	0.00757	CbGpPWpGaD
Fosaprepitant—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00159	0.00211	CcSEcCtD
Fosaprepitant—Decreased appetite—Galantamine—Alzheimer's disease	0.00158	0.0021	CcSEcCtD
Fosaprepitant—Mental disorder—Memantine—Alzheimer's disease	0.00158	0.0021	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00157	0.00209	CcSEcCtD
Fosaprepitant—Malnutrition—Memantine—Alzheimer's disease	0.00157	0.00208	CcSEcCtD
Fosaprepitant—Fatigue—Galantamine—Alzheimer's disease	0.00157	0.00208	CcSEcCtD
Fosaprepitant—Malaise—Donepezil—Alzheimer's disease	0.00156	0.00207	CcSEcCtD
Fosaprepitant—Constipation—Galantamine—Alzheimer's disease	0.00156	0.00207	CcSEcCtD
Fosaprepitant—Syncope—Donepezil—Alzheimer's disease	0.00155	0.00206	CcSEcCtD
Fosaprepitant—Flatulence—Memantine—Alzheimer's disease	0.00155	0.00205	CcSEcCtD
Fosaprepitant—Mental disorder—Rivastigmine—Alzheimer's disease	0.00154	0.00205	CcSEcCtD
Fosaprepitant—Dysgeusia—Memantine—Alzheimer's disease	0.00154	0.00204	CcSEcCtD
Fosaprepitant—Malnutrition—Rivastigmine—Alzheimer's disease	0.00153	0.00204	CcSEcCtD
Fosaprepitant—Erythema—Rivastigmine—Alzheimer's disease	0.00153	0.00204	CcSEcCtD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	0.00152	0.00722	CbGpPWpGaD
Fosaprepitant—Loss of consciousness—Donepezil—Alzheimer's disease	0.00152	0.00202	CcSEcCtD
Fosaprepitant—Flatulence—Rivastigmine—Alzheimer's disease	0.00151	0.00201	CcSEcCtD
Fosaprepitant—Cough—Donepezil—Alzheimer's disease	0.00151	0.002	CcSEcCtD
Fosaprepitant—Dysgeusia—Rivastigmine—Alzheimer's disease	0.0015	0.002	CcSEcCtD
Fosaprepitant—Feeling abnormal—Galantamine—Alzheimer's disease	0.0015	0.00199	CcSEcCtD
Fosaprepitant—Hypertension—Donepezil—Alzheimer's disease	0.00149	0.00198	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00149	0.00198	CcSEcCtD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	0.00148	0.00704	CbGpPWpGaD
Fosaprepitant—Muscle spasms—Rivastigmine—Alzheimer's disease	0.00148	0.00196	CcSEcCtD
Fosaprepitant—Chest pain—Donepezil—Alzheimer's disease	0.00147	0.00195	CcSEcCtD
Fosaprepitant—Anxiety—Donepezil—Alzheimer's disease	0.00147	0.00195	CcSEcCtD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CCR5—Alzheimer's disease	0.00146	0.00694	CbGpPWpGaD
Fosaprepitant—Ill-defined disorder—Memantine—Alzheimer's disease	0.00146	0.00193	CcSEcCtD
Fosaprepitant—Discomfort—Donepezil—Alzheimer's disease	0.00145	0.00193	CcSEcCtD
Fosaprepitant—Anaemia—Memantine—Alzheimer's disease	0.00145	0.00193	CcSEcCtD
Fosaprepitant—TACR1—G alpha (q) signalling events—HTR2A—Alzheimer's disease	0.00145	0.00688	CbGpPWpGaD
Fosaprepitant—Dry mouth—Donepezil—Alzheimer's disease	0.00144	0.00191	CcSEcCtD
Fosaprepitant—Abdominal pain—Galantamine—Alzheimer's disease	0.00144	0.00191	CcSEcCtD
Fosaprepitant—Body temperature increased—Galantamine—Alzheimer's disease	0.00144	0.00191	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00142	0.00189	CcSEcCtD
Fosaprepitant—Anaemia—Rivastigmine—Alzheimer's disease	0.00142	0.00188	CcSEcCtD
Fosaprepitant—Malaise—Memantine—Alzheimer's disease	0.00141	0.00188	CcSEcCtD
Fosaprepitant—Oedema—Donepezil—Alzheimer's disease	0.00141	0.00187	CcSEcCtD
Fosaprepitant—Syncope—Memantine—Alzheimer's disease	0.00141	0.00187	CcSEcCtD
Fosaprepitant—Infection—Donepezil—Alzheimer's disease	0.0014	0.00186	CcSEcCtD
Fosaprepitant—Shock—Donepezil—Alzheimer's disease	0.00139	0.00184	CcSEcCtD
Fosaprepitant—Palpitations—Memantine—Alzheimer's disease	0.00139	0.00184	CcSEcCtD
Fosaprepitant—Malaise—Rivastigmine—Alzheimer's disease	0.00138	0.00184	CcSEcCtD
Fosaprepitant—Nervous system disorder—Donepezil—Alzheimer's disease	0.00138	0.00184	CcSEcCtD
Fosaprepitant—Loss of consciousness—Memantine—Alzheimer's disease	0.00138	0.00183	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—PYY—Alzheimer's disease	0.00138	0.00654	CbGpPWpGaD
Fosaprepitant—Syncope—Rivastigmine—Alzheimer's disease	0.00138	0.00183	CcSEcCtD
Fosaprepitant—Cough—Memantine—Alzheimer's disease	0.00137	0.00182	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00136	0.00181	CcSEcCtD
Fosaprepitant—Palpitations—Rivastigmine—Alzheimer's disease	0.00136	0.0018	CcSEcCtD
Fosaprepitant—Hypertension—Memantine—Alzheimer's disease	0.00135	0.0018	CcSEcCtD
Fosaprepitant—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00135	0.00179	CcSEcCtD
Fosaprepitant—Hypersensitivity—Galantamine—Alzheimer's disease	0.00134	0.00178	CcSEcCtD
Fosaprepitant—Cough—Rivastigmine—Alzheimer's disease	0.00134	0.00178	CcSEcCtD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	0.00134	0.00635	CbGpPWpGaD
Fosaprepitant—Chest pain—Memantine—Alzheimer's disease	0.00134	0.00177	CcSEcCtD
Fosaprepitant—TACR1—Spinal Cord Injury—PTGS2—Alzheimer's disease	0.00133	0.00633	CbGpPWpGaD
Fosaprepitant—Anxiety—Memantine—Alzheimer's disease	0.00133	0.00177	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—NPY—Alzheimer's disease	0.00133	0.0063	CbGpPWpGaD
Fosaprepitant—Hypertension—Rivastigmine—Alzheimer's disease	0.00133	0.00176	CcSEcCtD
Fosaprepitant—Discomfort—Memantine—Alzheimer's disease	0.00132	0.00175	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—IAPP—Alzheimer's disease	0.00132	0.00626	CbGpPWpGaD
Fosaprepitant—Hypotension—Donepezil—Alzheimer's disease	0.00132	0.00175	CcSEcCtD
Fosaprepitant—Chest pain—Rivastigmine—Alzheimer's disease	0.00131	0.00173	CcSEcCtD
Fosaprepitant—Dry mouth—Memantine—Alzheimer's disease	0.00131	0.00173	CcSEcCtD
Fosaprepitant—Asthenia—Galantamine—Alzheimer's disease	0.00131	0.00173	CcSEcCtD
Fosaprepitant—Anxiety—Rivastigmine—Alzheimer's disease	0.0013	0.00173	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.0013	0.00172	CcSEcCtD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Alzheimer's disease	0.00129	0.00615	CbGpPWpGaD
Fosaprepitant—Discomfort—Rivastigmine—Alzheimer's disease	0.00129	0.00171	CcSEcCtD
Fosaprepitant—Oedema—Memantine—Alzheimer's disease	0.00128	0.0017	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—CRH—Alzheimer's disease	0.00128	0.00608	CbGpPWpGaD
Fosaprepitant—Dry mouth—Rivastigmine—Alzheimer's disease	0.00128	0.0017	CcSEcCtD
Fosaprepitant—Insomnia—Donepezil—Alzheimer's disease	0.00128	0.00169	CcSEcCtD
Fosaprepitant—Infection—Memantine—Alzheimer's disease	0.00127	0.00169	CcSEcCtD
Fosaprepitant—TACR1—G alpha (q) signalling events—F2—Alzheimer's disease	0.00127	0.00603	CbGpPWpGaD
Fosaprepitant—Shock—Memantine—Alzheimer's disease	0.00126	0.00167	CcSEcCtD
Fosaprepitant—Dyspnoea—Donepezil—Alzheimer's disease	0.00126	0.00167	CcSEcCtD
Fosaprepitant—Nervous system disorder—Memantine—Alzheimer's disease	0.00126	0.00167	CcSEcCtD
Fosaprepitant—Somnolence—Donepezil—Alzheimer's disease	0.00125	0.00166	CcSEcCtD
Fosaprepitant—Oedema—Rivastigmine—Alzheimer's disease	0.00125	0.00166	CcSEcCtD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—F2—Alzheimer's disease	0.00125	0.00595	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PYY—Alzheimer's disease	0.00125	0.00594	CbGpPWpGaD
Fosaprepitant—Diarrhoea—Galantamine—Alzheimer's disease	0.00125	0.00165	CcSEcCtD
Fosaprepitant—Infection—Rivastigmine—Alzheimer's disease	0.00124	0.00165	CcSEcCtD
Fosaprepitant—Skin disorder—Memantine—Alzheimer's disease	0.00124	0.00165	CcSEcCtD
Fosaprepitant—Dyspepsia—Donepezil—Alzheimer's disease	0.00124	0.00165	CcSEcCtD
Fosaprepitant—TACR1—Spinal Cord Injury—IL1B—Alzheimer's disease	0.00124	0.00589	CbGpPWpGaD
Fosaprepitant—Hyperhidrosis—Memantine—Alzheimer's disease	0.00124	0.00164	CcSEcCtD
Fosaprepitant—TACR1—Spinal Cord Injury—CASP3—Alzheimer's disease	0.00124	0.00588	CbGpPWpGaD
Fosaprepitant—Shock—Rivastigmine—Alzheimer's disease	0.00123	0.00164	CcSEcCtD
Fosaprepitant—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00123	0.00163	CcSEcCtD
Fosaprepitant—Decreased appetite—Donepezil—Alzheimer's disease	0.00123	0.00163	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00122	0.00162	CcSEcCtD
Fosaprepitant—Skin disorder—Rivastigmine—Alzheimer's disease	0.00122	0.00162	CcSEcCtD
Fosaprepitant—Fatigue—Donepezil—Alzheimer's disease	0.00122	0.00161	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—NPS—Alzheimer's disease	0.00121	0.00576	CbGpPWpGaD
Fosaprepitant—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00121	0.00161	CcSEcCtD
Fosaprepitant—Pain—Donepezil—Alzheimer's disease	0.00121	0.0016	CcSEcCtD
Fosaprepitant—Constipation—Donepezil—Alzheimer's disease	0.00121	0.0016	CcSEcCtD
Fosaprepitant—Dizziness—Galantamine—Alzheimer's disease	0.0012	0.0016	CcSEcCtD
Fosaprepitant—Hypotension—Memantine—Alzheimer's disease	0.0012	0.00159	CcSEcCtD
Fosaprepitant—Hypotension—Rivastigmine—Alzheimer's disease	0.00117	0.00155	CcSEcCtD
Fosaprepitant—Feeling abnormal—Donepezil—Alzheimer's disease	0.00116	0.00154	CcSEcCtD
Fosaprepitant—Insomnia—Memantine—Alzheimer's disease	0.00116	0.00154	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—SST—Alzheimer's disease	0.00116	0.0055	CbGpPWpGaD
Fosaprepitant—Vomiting—Galantamine—Alzheimer's disease	0.00116	0.00154	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00115	0.00153	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—HTR6—Alzheimer's disease	0.00115	0.00546	CbGpPWpGaD
Fosaprepitant—Rash—Galantamine—Alzheimer's disease	0.00115	0.00152	CcSEcCtD
Fosaprepitant—Dermatitis—Galantamine—Alzheimer's disease	0.00115	0.00152	CcSEcCtD
Fosaprepitant—Dyspnoea—Memantine—Alzheimer's disease	0.00114	0.00152	CcSEcCtD
Fosaprepitant—Headache—Galantamine—Alzheimer's disease	0.00114	0.00151	CcSEcCtD
Fosaprepitant—Somnolence—Memantine—Alzheimer's disease	0.00114	0.00151	CcSEcCtD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—Alzheimer's disease	0.00113	0.00539	CbGpPWpGaD
Fosaprepitant—Insomnia—Rivastigmine—Alzheimer's disease	0.00113	0.0015	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—APP—Alzheimer's disease	0.00113	0.00536	CbGpPWpGaD
Fosaprepitant—Dyspepsia—Memantine—Alzheimer's disease	0.00113	0.0015	CcSEcCtD
Fosaprepitant—Urticaria—Donepezil—Alzheimer's disease	0.00112	0.00149	CcSEcCtD
Fosaprepitant—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00112	0.00148	CcSEcCtD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CCL2—Alzheimer's disease	0.00112	0.00531	CbGpPWpGaD
Fosaprepitant—Abdominal pain—Donepezil—Alzheimer's disease	0.00111	0.00148	CcSEcCtD
Fosaprepitant—Body temperature increased—Donepezil—Alzheimer's disease	0.00111	0.00148	CcSEcCtD
Fosaprepitant—Somnolence—Rivastigmine—Alzheimer's disease	0.00111	0.00148	CcSEcCtD
Fosaprepitant—Decreased appetite—Memantine—Alzheimer's disease	0.00111	0.00148	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00111	0.00147	CcSEcCtD
Fosaprepitant—Fatigue—Memantine—Alzheimer's disease	0.0011	0.00147	CcSEcCtD
Fosaprepitant—Dyspepsia—Rivastigmine—Alzheimer's disease	0.0011	0.00146	CcSEcCtD
Fosaprepitant—Constipation—Memantine—Alzheimer's disease	0.0011	0.00145	CcSEcCtD
Fosaprepitant—Pain—Memantine—Alzheimer's disease	0.0011	0.00145	CcSEcCtD
Fosaprepitant—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00109	0.00145	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—CDK5—Alzheimer's disease	0.00108	0.00515	CbGpPWpGaD
Fosaprepitant—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00108	0.00144	CcSEcCtD
Fosaprepitant—Nausea—Galantamine—Alzheimer's disease	0.00108	0.00144	CcSEcCtD
Fosaprepitant—Fatigue—Rivastigmine—Alzheimer's disease	0.00108	0.00143	CcSEcCtD
Fosaprepitant—Constipation—Rivastigmine—Alzheimer's disease	0.00107	0.00142	CcSEcCtD
Fosaprepitant—Pain—Rivastigmine—Alzheimer's disease	0.00107	0.00142	CcSEcCtD
Fosaprepitant—Feeling abnormal—Memantine—Alzheimer's disease	0.00106	0.0014	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00105	0.00139	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—HTR6—Alzheimer's disease	0.00104	0.00496	CbGpPWpGaD
Fosaprepitant—Hypersensitivity—Donepezil—Alzheimer's disease	0.00104	0.00138	CcSEcCtD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—Alzheimer's disease	0.00103	0.00491	CbGpPWpGaD
Fosaprepitant—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00103	0.00137	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00102	0.00136	CcSEcCtD
Fosaprepitant—Urticaria—Memantine—Alzheimer's disease	0.00102	0.00135	CcSEcCtD
Fosaprepitant—Abdominal pain—Memantine—Alzheimer's disease	0.00101	0.00134	CcSEcCtD
Fosaprepitant—Body temperature increased—Memantine—Alzheimer's disease	0.00101	0.00134	CcSEcCtD
Fosaprepitant—Asthenia—Donepezil—Alzheimer's disease	0.00101	0.00134	CcSEcCtD
Fosaprepitant—Pruritus—Donepezil—Alzheimer's disease	0.000998	0.00132	CcSEcCtD
Fosaprepitant—Urticaria—Rivastigmine—Alzheimer's disease	0.000995	0.00132	CcSEcCtD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	0.000991	0.00471	CbGpPWpGaD
Fosaprepitant—Body temperature increased—Rivastigmine—Alzheimer's disease	0.00099	0.00131	CcSEcCtD
Fosaprepitant—Abdominal pain—Rivastigmine—Alzheimer's disease	0.00099	0.00131	CcSEcCtD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	0.000989	0.0047	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.000979	0.00465	CbGpPWpGaD
Fosaprepitant—Diarrhoea—Donepezil—Alzheimer's disease	0.000965	0.00128	CcSEcCtD
Fosaprepitant—TACR1—Spinal Cord Injury—TGFB1—Alzheimer's disease	0.000963	0.00458	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.000958	0.00455	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—GAL—Alzheimer's disease	0.000954	0.00453	CbGpPWpGaD
Fosaprepitant—Hypersensitivity—Memantine—Alzheimer's disease	0.000943	0.00125	CcSEcCtD
Fosaprepitant—Dizziness—Donepezil—Alzheimer's disease	0.000933	0.00124	CcSEcCtD
Fosaprepitant—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000923	0.00123	CcSEcCtD
Fosaprepitant—Asthenia—Memantine—Alzheimer's disease	0.000919	0.00122	CcSEcCtD
Fosaprepitant—Pruritus—Memantine—Alzheimer's disease	0.000906	0.0012	CcSEcCtD
Fosaprepitant—TACR1—Spinal Cord Injury—TNF—Alzheimer's disease	0.000899	0.00427	CbGpPWpGaD
Fosaprepitant—Asthenia—Rivastigmine—Alzheimer's disease	0.000899	0.00119	CcSEcCtD
Fosaprepitant—Vomiting—Donepezil—Alzheimer's disease	0.000897	0.00119	CcSEcCtD
Fosaprepitant—Rash—Donepezil—Alzheimer's disease	0.000889	0.00118	CcSEcCtD
Fosaprepitant—Dermatitis—Donepezil—Alzheimer's disease	0.000888	0.00118	CcSEcCtD
Fosaprepitant—Pruritus—Rivastigmine—Alzheimer's disease	0.000886	0.00118	CcSEcCtD
Fosaprepitant—Headache—Donepezil—Alzheimer's disease	0.000884	0.00117	CcSEcCtD
Fosaprepitant—Diarrhoea—Memantine—Alzheimer's disease	0.000876	0.00116	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—GAL—Alzheimer's disease	0.000866	0.00412	CbGpPWpGaD
Fosaprepitant—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000857	0.00114	CcSEcCtD
Fosaprepitant—Dizziness—Memantine—Alzheimer's disease	0.000847	0.00112	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—TTR—Alzheimer's disease	0.000845	0.00402	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.00084	0.00399	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	0.000839	0.00399	CbGpPWpGaD
Fosaprepitant—Nausea—Donepezil—Alzheimer's disease	0.000838	0.00111	CcSEcCtD
Fosaprepitant—Dizziness—Rivastigmine—Alzheimer's disease	0.000828	0.0011	CcSEcCtD
Fosaprepitant—Vomiting—Memantine—Alzheimer's disease	0.000814	0.00108	CcSEcCtD
Fosaprepitant—Rash—Memantine—Alzheimer's disease	0.000807	0.00107	CcSEcCtD
Fosaprepitant—Dermatitis—Memantine—Alzheimer's disease	0.000807	0.00107	CcSEcCtD
Fosaprepitant—Headache—Memantine—Alzheimer's disease	0.000802	0.00107	CcSEcCtD
Fosaprepitant—Vomiting—Rivastigmine—Alzheimer's disease	0.000796	0.00106	CcSEcCtD
Fosaprepitant—TACR1—Spinal Cord Injury—TP53—Alzheimer's disease	0.000793	0.00377	CbGpPWpGaD
Fosaprepitant—Rash—Rivastigmine—Alzheimer's disease	0.00079	0.00105	CcSEcCtD
Fosaprepitant—Dermatitis—Rivastigmine—Alzheimer's disease	0.000789	0.00105	CcSEcCtD
Fosaprepitant—Headache—Rivastigmine—Alzheimer's disease	0.000785	0.00104	CcSEcCtD
Fosaprepitant—Nausea—Memantine—Alzheimer's disease	0.000761	0.00101	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—NPY—Alzheimer's disease	0.00075	0.00356	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000749	0.00356	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCR5—Alzheimer's disease	0.000746	0.00354	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000745	0.00354	CbGpPWpGaD
Fosaprepitant—Nausea—Rivastigmine—Alzheimer's disease	0.000744	0.000988	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—PYY—Alzheimer's disease	0.000738	0.00351	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—HTR2A—Alzheimer's disease	0.00073	0.00347	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—IL6—Alzheimer's disease	0.000726	0.00345	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CRH—Alzheimer's disease	0.000723	0.00344	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	0.000719	0.00342	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—NPS—Alzheimer's disease	0.000686	0.00326	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—NPY—Alzheimer's disease	0.000681	0.00323	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—IAPP—Alzheimer's disease	0.000676	0.00321	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CRH—Alzheimer's disease	0.000657	0.00312	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—SST—Alzheimer's disease	0.000654	0.00311	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000654	0.00311	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CDK5—Alzheimer's disease	0.00064	0.00304	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—F2—Alzheimer's disease	0.00064	0.00304	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—APP—Alzheimer's disease	0.000637	0.00303	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—NPS—Alzheimer's disease	0.000623	0.00296	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000619	0.00294	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HTR6—Alzheimer's disease	0.000616	0.00293	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000601	0.00286	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—SST—Alzheimer's disease	0.000594	0.00282	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—GAB2—Alzheimer's disease	0.000594	0.00282	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	0.000581	0.00276	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—APP—Alzheimer's disease	0.000579	0.00275	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CCL2—Alzheimer's disease	0.00057	0.00271	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PSENEN—Alzheimer's disease	0.00056	0.00266	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—APH1A—Alzheimer's disease	0.000552	0.00262	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000546	0.0026	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NCSTN—Alzheimer's disease	0.000537	0.00255	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—LRP1—Alzheimer's disease	0.000524	0.00249	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—GFAP—Alzheimer's disease	0.000512	0.00243	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—GAL—Alzheimer's disease	0.000512	0.00243	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—A2M—Alzheimer's disease	0.000451	0.00214	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	0.000449	0.00213	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000445	0.00211	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PSEN2—Alzheimer's disease	0.000437	0.00208	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000421	0.002	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000412	0.00196	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000404	0.00192	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NPY—Alzheimer's disease	0.000402	0.00191	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IAPP—Alzheimer's disease	0.0004	0.0019	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CRH—Alzheimer's disease	0.000388	0.00184	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCR5—Alzheimer's disease	0.000383	0.00182	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000375	0.00178	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NPS—Alzheimer's disease	0.000368	0.00175	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000366	0.00174	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—F2—Alzheimer's disease	0.000362	0.00172	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PTK2B—Alzheimer's disease	0.000361	0.00171	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NTRK2—Alzheimer's disease	0.000351	0.00167	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—GAB2—Alzheimer's disease	0.000351	0.00167	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—SST—Alzheimer's disease	0.000351	0.00167	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CALM1—Alzheimer's disease	0.000349	0.00166	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—GSK3A—Alzheimer's disease	0.000348	0.00165	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—APP—Alzheimer's disease	0.000342	0.00162	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—F2—Alzheimer's disease	0.000328	0.00156	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PLCB1—Alzheimer's disease	0.000323	0.00153	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NGFR—Alzheimer's disease	0.000301	0.00143	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CREB1—Alzheimer's disease	0.000299	0.00142	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—ADAM10—Alzheimer's disease	0.000294	0.0014	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCL2—Alzheimer's disease	0.000293	0.00139	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—S100B—Alzheimer's disease	0.000278	0.00132	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IGF2—Alzheimer's disease	0.000265	0.00126	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IGF1R—Alzheimer's disease	0.000256	0.00122	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—LPL—Alzheimer's disease	0.000245	0.00117	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MEF2C—Alzheimer's disease	0.000243	0.00116	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PRKCG—Alzheimer's disease	0.000239	0.00113	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NGF—Alzheimer's disease	0.000232	0.0011	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCR5—Alzheimer's disease	0.000226	0.00107	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HTR2A—Alzheimer's disease	0.000221	0.00105	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CALM1—Alzheimer's disease	0.000206	0.000981	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—APOE—Alzheimer's disease	0.000206	0.000977	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—LEP—Alzheimer's disease	0.000206	0.000977	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CAV1—Alzheimer's disease	0.000204	0.000968	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—ESR1—Alzheimer's disease	0.000196	0.000933	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—F2—Alzheimer's disease	0.000194	0.000922	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NOTCH1—Alzheimer's disease	0.00019	0.000902	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—GSK3B—Alzheimer's disease	0.000178	0.000846	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CREB1—Alzheimer's disease	0.000177	0.00084	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—INS—Alzheimer's disease	0.000176	0.000835	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCL2—Alzheimer's disease	0.000173	0.000822	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IGF1—Alzheimer's disease	0.00017	0.000808	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NOS3—Alzheimer's disease	0.000154	0.000732	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—AKT1—Alzheimer's disease	0.000132	0.000627	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CASP3—Alzheimer's disease	0.000131	0.000622	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—IL6—Alzheimer's disease	0.00013	0.000618	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MAPK8—Alzheimer's disease	0.00012	0.000571	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—AKT1—Alzheimer's disease	0.00012	0.00057	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—VEGFA—Alzheimer's disease	0.000111	0.000528	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TGFB1—Alzheimer's disease	0.000102	0.000484	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TP53—Alzheimer's disease	8.39e-05	0.000399	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IL6—Alzheimer's disease	7.68e-05	0.000365	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—AKT1—Alzheimer's disease	7.08e-05	0.000337	CbGpPWpGaD
